WOONSOCKET, R.I. — Pharmacy gains propelled CVS Health’s second quarter results ahead of Wall Street’s expectations. Retail sales for the three months ended June 30 climbed 5.7% to $20.7 billion, despite less front-end traffic. Overall same-store sales rose 5.9%. Pharmacy sales jumped 8.3% from a year ago, while same-store front-end sales dipped 1%. CVS’ revenue
WOONSOCKET, R.I. — CVS Health topped Wall Street’s earnings-per-share forecast and, driven largely by its PBM unit, saw double-digit sales gains for the 2016 fourth quarter and full year. CVS said Thursday that for the fourth quarter ended Dec. 31, revenue totaled $45.97 billion, up 11.7% from $41.15 billion a year earlier. For the 2016
WOONSOCKET, R.I. — CVS Health reported strong sales gains and topped Wall Street’s consensus earnings forecast for the 2016 first quarter. CVS said Tuesday that for the three months ended March 31, overall revenue climbed 18.9% to $43.2 billion from $36.3 billion a year earlier. Sales in the Retail/LTC Segment, which includes CVS Pharmacy drug